AMH/MIS as a contraceptive that protects the ovarian reserve during chemotherapy - Wikidata - awgldk - TriplyDB

AMH/MIS as a contraceptive that protects the ovarian reserve during chemotherapy

AMH/MIS as a contraceptive that protects the ovarian reserve during chemotherapy

http://www.wikidata.org/entity/Q30353654

about

Understanding follicle growth in vitro: Are we getting closer to obtaining mature oocytes from in vitro-grown follicles in human?Potential therapeutic applications of human anti-Müllerian hormone (AMH) analogues in reproductive medicine.A win-win for women's reproductive health: A nonsteroidal contraceptive and fertoprotective neoadjuvant.Pathogenic Anti-Müllerian Hormone Variants in Polycystic Ovary Syndrome.Ovarian tissue cryopreservation and transplantation in patients with cancer.Xenotransplantation of pre-pubertal ovarian cortex and prevention of follicle depletion with anti-Müllerian hormone (AMH)Protective effects of mangafodipir against chemotherapy-induced ovarian damage in mice

P2860

Q39269056-0B07090B-15BD-47FD-8AFD-552CE4A7CDA3 Q39393122-BFA2383C-E256-438B-8040-FD5AD81F397D Q41788485-16662186-EEC1-4EF3-996B-5E6D353FAB51 Q47214502-39C26347-640E-47E6-B0D6-A338338248D5 Q55689271-2AA192ED-1177-4AF4-A992-38DBE8A7D9C2 Q57090910-319FB45F-CD5F-4807-8693-4402E93F7EBF Q58112099-4C06C6A6-9EC2-45FE-B2E5-C4DE8B371CD0

P2860

AMH/MIS as a contraceptive that protects the ovarian reserve during chemotherapy

http://www.wikidata.org/entity/Q30353654

description

2017 nî lūn-bûn

@nan

2017 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

name

AMH/MIS as a contraceptive that protects the ovarian reserve during chemotherapy

@ast

AMH/MIS as a contraceptive that protects the ovarian reserve during chemotherapy

@en

type

label

AMH/MIS as a contraceptive that protects the ovarian reserve during chemotherapy

@ast

AMH/MIS as a contraceptive that protects the ovarian reserve during chemotherapy

@en

prefLabel

AMH/MIS as a contraceptive that protects the ovarian reserve during chemotherapy

@ast

AMH/MIS as a contraceptive that protects the ovarian reserve during chemotherapy

@en

P1433

Q30353654-7C3369F5-7BD9-41C4-9A7E-A1B4FBE8A920

P1476

Q30353654-CBA36060-5D47-4CF5-8A13-0017350E4DC9

P2093

Q30353654-32C93327-A9D7-4F00-8A7A-CF0D9C873EF2

Q30353654-355ADC76-85CA-42CA-AC2A-069C9F7ED9F2

Q30353654-56310B05-A565-420B-9C64-DB6C6CF21F62

Q30353654-66151707-FD48-451E-88E4-CEC52F3E6C73

Q30353654-7799DC22-A415-445E-A105-3B77974F47DF

Q30353654-B1ECF71C-C056-4565-B8D0-047F1BB7DA3C

Q30353654-C7E2291A-5BB8-40FC-84DC-A648F2CB04B5

Q30353654-CA556AF6-F4EB-42F0-BED1-3E77C2AE4D2D

P2860

Q30353654-020807E8-9792-4185-BCA5-C9987776CAB8

Q30353654-0B08B5E3-DF3C-42DD-BF3F-8D73AFE11066

Q30353654-0B41DAD2-64C0-440F-88C9-6CC74CA88C7D

Q30353654-16E170D5-6C46-4E0F-B362-2DC82FD6148A

Q30353654-1755D08F-EB74-4651-8B66-B793EF5BEEF6

Q30353654-1D8EE846-5416-4BDC-A215-ECD84DE79C17

Q30353654-1DECE135-6437-4FE0-93C3-18E80E7BC1E0

Q30353654-1EEDF3F9-CD60-479D-A495-C400BB4F3340

Q30353654-20EC53E0-5620-4FB1-8258-563A747A7042

Q30353654-2EB1276D-95DC-4E33-9CAD-AC12B88AD53E

P304

Q30353654-58FC6C83-58F0-4ABB-A9D9-CF0B1EEAB5D4

P31

Q30353654-C68257C3-F09A-4E6A-8535-D9F9C2061588

P356

Q30353654-49A3270E-9F2C-44B5-9D04-B28A62FDD05E

P407

Q30353654-D3845B9D-1E4E-4CC7-AA03-F4086F811A33

P433

Q30353654-378CB70B-278A-4373-93AF-B76A6118E79C

P478

Q30353654-C09BA2BD-13B2-4DE2-B181-4F5D640E34AF

P50

Q30353654-BCD33F59-221D-40BF-A385-4374CF569E0F

Q30353654-F0C7AEEE-9BD3-4756-9C94-2603492EED8A

P577

Q30353654-82B64EB8-568F-41C7-B7F6-4A6D870EB3FC

P698

Q30353654-5EB0CE43-607D-484C-BFEE-73F4067C84B5

P921

Q30353654-DA0E300F-B4B6-41D1-A222-98997E6C8A12

P932

Q30353654-B92B04AC-DC31-4EED-B38F-2440797095BE

P356

PNAS.1620729114

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

AMH/MIS as a contraceptive that protects the ovarian reserve during chemotherapy

@en

P2093

Amanda E Sosulski

http://www.w3.org/2001/XMLSchema#string

David Pépin

http://www.w3.org/2001/XMLSchema#string

Guangping Gao

http://www.w3.org/2001/XMLSchema#string

Hatice D Saatcioglu

http://www.w3.org/2001/XMLSchema#string

LiHua Zhang

http://www.w3.org/2001/XMLSchema#string

Mary E Sabatini

http://www.w3.org/2001/XMLSchema#string

Nicholas Nagykery

http://www.w3.org/2001/XMLSchema#string

Patricia K Donahoe

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells

Genetics of the ovarian reserve

Functional genomics of PCOS: from GWAS to molecular mechanisms

How do chemotherapeutic agents damage the ovary?

Requirement of Bmpr1a for Müllerian duct regression during male sexual development

A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the müllerian duct

Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study

Inhibitory actions of Anti-Müllerian Hormone (AMH) on ovarian primordial follicle assembly.

Preservation of fertility in patients with cancer.

The physiology and clinical utility of anti-Mullerian hormone in women.

P304

E1688-E1697

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1620729114

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

114

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-01-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28137855

http://www.w3.org/2001/XMLSchema#string

P921

P932

5338508

http://www.w3.org/2001/XMLSchema#string